Inari Medical Inc. (NARI)
NASDAQ: NARI
· Real-Time Price · USD
79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM
Inari Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 153.39M | 145.82M | 143.19M | 132.09M | 126.37M | 119M | 116.17M | 107.77M | 96.2M | 92.74M | 86.75M | 83.22M | 72.92M | 63.45M | 57.4M |
Cost of Revenue | 19.85M | 23.54M | 18.89M | 18.14M | 14.48M | 13.84M | 13.74M | 13.13M | 11.06M | 10.35M | 9.97M | 8.28M | 7.04M | 4.81M | 4.62M |
Gross Profit | 133.54M | 122.28M | 124.3M | 113.95M | 111.89M | 105.16M | 102.43M | 94.64M | 85.14M | 82.4M | 76.78M | 74.94M | 65.88M | 58.64M | 52.77M |
Operating Income | -13.57M | -15.68M | -17.18M | -1.6M | 2.11M | -1.51M | -1.15M | -5.89M | -9.8M | -9.33M | -3.08M | 1.75M | -2.73M | 4.11M | 7.71M |
Interest Income | 1.1M | 1.08M | 1.19M | 2.71M | 4.2M | 4.55M | 4.14M | 970K | 618K | 214K | 50K | 24K | 27K | 35K | 68K |
Pretax Income | -12.67M | -21.42M | -16.09M | -3.18M | 5.59M | 3.02M | -1.19M | -4.81M | -9.31M | -8.94M | -3.13M | 1.68M | -2.74M | 4.08M | 7.67M |
Net Income | -18.37M | -31.35M | -24.2M | -4.67M | 3.16M | 2.08M | -2.22M | -5.8M | -10.15M | -10.19M | -3.18M | 1.11M | -2.8M | 4.07M | 7.47M |
Selling & General & Admin | 108.27M | 113.05M | 103.06M | 92.66M | 88.28M | 85.59M | 85.7M | 80.12M | 75.83M | 73.16M | 63.73M | 54.47M | 56.1M | 42.9M | 36.9M |
Research & Development | 29.43M | 24.91M | 26.88M | 22.89M | 21.49M | 21.09M | 22.06M | 20.41M | 19.11M | 18.57M | 16.14M | 18.73M | 12.5M | 11.63M | 8.16M |
Other Expenses | 9.41M | 23K | -23K | n/a | -682K | 26K | 39K | 187K | -59K | 252K | -24K | -14K | 30K | 7K | -41K |
Operating Expenses | 147.11M | 137.96M | 132.4M | 115.55M | 109.78M | 106.67M | 107.76M | 100.53M | 94.94M | 91.72M | 79.87M | 73.19M | 68.6M | 54.53M | 45.06M |
Interest Expense | 78K | 77K | 78K | 69K | 43K | 44K | 40K | 74K | 74K | 73K | 73K | 75K | 73K | 74K | 73K |
Selling & Marketing Expenses | n/a | n/a | n/a | 1.2M | n/a | n/a | n/a | 957K | n/a | n/a | n/a | 344K | n/a | n/a | n/a |
Cost & Expenses | 166.96M | 161.5M | 151.29M | 133.69M | 124.25M | 120.52M | 121.5M | 113.66M | 106M | 102.07M | 89.83M | 81.47M | 75.64M | 59.34M | 49.68M |
Income Tax Expense | 5.7M | 9.93M | 8.12M | 1.49M | 2.43M | 939K | 1.02M | 990K | 840K | 1.25M | 47K | 574K | 61K | 12K | 198K |
Shares Outstanding (Basic) | 58.37M | 58.14M | 57.94M | 57.64M | 57.38M | 57.21M | 54.76M | 53.61M | 53.44M | 53.18M | 50.95M | 50.23M | 50M | 49.67M | 49.36M |
Shares Outstanding (Diluted) | 58.37M | 58.14M | 57.94M | 57.64M | 58.59M | 58.5M | 54.76M | 53.61M | 53.49M | 53.18M | 50.95M | 55.63M | 50M | 55.6M | 55.72M |
EPS (Basic) | -0.31 | -0.54 | -0.42 | -0.08 | 0.06 | 0.04 | -0.04 | -0.11 | -0.19 | -0.19 | -0.06 | 0.02 | -0.06 | 0.08 | 0.15 |
EPS (Diluted) | -0.31 | -0.54 | -0.42 | -0.08 | 0.05 | 0.04 | -0.04 | -0.11 | -0.19 | -0.19 | -0.06 | 0.02 | -0.06 | 0.07 | 0.13 |
EBITDA | -7.21M | -16.61M | -11.39M | -947K | 7.8M | 5.21M | 1.82M | -2.84M | -7.5M | -7.04M | -1.39M | 3.47M | -1.6M | 5.08M | 8.57M |
EBIT | -12.59M | -21.34M | -16.01M | -3.1M | 2.11M | 3.07M | -1.15M | -4.73M | -9.24M | -8.86M | -3.06M | 1.76M | -2.67M | 4.11M | 7.71M |
Depreciation & Amortization | 5.38M | 4.74M | 4.62M | 2.16M | 2.17M | 2.14M | 2.97M | 1.89M | 1.74M | 1.82M | 1.67M | 1.71M | 1.07M | 924K | 827K |